Journal Article

Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy

Richardson, Timothy E, Sakai, Kenji, Stein, Thor D, Corrada, María, Keene, C Dirk, Hansen, Lawrence A, Kovacs, Gabor G, Walker, Jamie M, Attems, Johannes, Schneider, Julie A, Purohit, Dushyant P, Sano, Mary, Iida, Megan A, Masliah, Eliezer, Vonsattel, Jean-Paul, Rissman, Robert A, Flanagan, Margaret E, Gearing, Marla, White, Charles L, Weintraub, Sandra, Haroutunian, Vahram, Cortes, Etty, Franklin, Erin, Nelson, Peter T, Murray, Melissa, Kofler, Julia, Budson, Andrew, Dickson, Dennis W, Poon, Wayne, Glass, Jonathan, Teich, Andrew F, Shang, Ping, Beach, Thomas G, Kawas, Claudia, Yamada, Masahito, Woltjer, Randall L, Bigio, Eileen H, Crary, John F, Hof, Patrick R, Troncoso, Juan C, Lee, Edward B, Trojanowski, John Q, Ayalon, Gai, Farrell, Kurt, Mao, Qinwen, Honig, Lawrence, Pham, Thao, Mesulam, M Marsel, Wolk, David A, McMillan, Corey T, Foong, Chan, Yu, Lei, Perrin, Richard, McKee, Ann C, Cairns, Nigel J, Fischer, Peter, Lutz, Mirjam I

2021

Overview

Abstract Primary age-related tauopathy (PART) is a neurodegenerative entity defined as Alzheimer-type neurofibrillary degeneration primarily affecting the medial temporal lobe with minimal to absent amyloid-β (Aβ) plaque deposition. The extent to which PART can be differentiated pathoanatomically from Alzheimer disease (AD) is unclear. Here, we examined the regional distribution of tau pathology in a large cohort of postmortem brains (n = 914). We found an early vulnerability of the CA2 subregion of the hippocampus to neurofibrillary degeneration in PART, and semiquantitative assessment of neurofibrillary degeneration in CA2 was significantly greater than in CA1 in PART. In contrast, subjects harboring intermediate-to-high AD neuropathologic change (ADNC) displayed relative sparing of CA2 until later stages of their disease course. In addition, the CA2/CA1 ratio of neurofibrillary degeneration in PART was significantly higher than in subjects with intermediate-to-high ADNC burden. Furthermore, the distribution of tau pathology in PART diverges from the Braak NFT staging system and Braak stage does not correlate with cognitive function in PART as it does in individuals with intermediate-to-high ADNC. These findings highlight the need for a better understanding of the contribution of PART to cognitive impairment and how neurofibrillary degeneration interacts with Aβ pathology in AD and PART.

• Publisher: Oxford University Press
• Subject: Age factors in disease / Aged / Aged, 80 and over / Aging - metabolism / Aging - pathology / Amyloid beta-Peptides - metabolism / Brain diseases / CA2 Region, Hippocampal - metabolism / CA2 Region, Hippocampal - pathology / Degeneration / Development and progression / Female / Health aspects / Hippocampus (Brain) / Humans / Male / Middle Aged / Nervous system / Neurofibrillary Tangles - metabolism / Neurofibrillary Tangles - pathology / Neurons - metabolism / Neurons - pathology / Original / Pathology / Plaque, Amyloid - metabolism / Plaque, Amyloid - pathology / Risk factors / Tau proteins / tau Proteins - metabolism / Tauopathies - metabolism / Tauopathies - pathology